TransMedics Group, Inc. TMDX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.80% | -57.94% | -71.52% | 1,436.87% | 476.83% |
| Total Depreciation and Amortization | 52.57% | 49.14% | 81.91% | 22.68% | 24.57% |
| Total Amortization of Deferred Charges | 150.00% | 100.00% | -- | -- | -- |
| Total Other Non-Cash Items | 130.48% | 82.19% | 71.79% | -663.34% | 20.21% |
| Change in Net Operating Assets | -157.46% | -163.32% | 74.43% | 8.44% | 348.30% |
| Cash from Operations | -48.25% | -81.11% | 959.30% | 75.52% | 914.63% |
| Capital Expenditure | -10.18% | 21.85% | -35.58% | -14.02% | 84.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -79.83% | 21.85% | -35.58% | -14.02% | 84.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -14.66% | -85.77% | 28.80% | 161.30% | -51.93% |
| Repurchase of Common Stock | -1.45% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -152.60% | -86.32% | 24.24% | 161.30% | -53.69% |
| Foreign Exchange rate Adjustments | -1,122.22% | -131.03% | -191.34% | 113.68% | -97.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.07% | -87.91% | 67.22% | 238.50% | 300.87% |